ALK and non-small cell lung carcinoma: It is reported that they tried to build a radiomic signature to predict pre-treatment BM for ALK-positive NSCLC patients and found that only 5 radiomic features were independent predictors (AUC=0.828), but they only performed internal test, therefore the independent model assessment could not be committed to avoid overfitting.